Jin-Tai Yu Selected Research

Amyloid Plaque

11/2017	Spreading of Pathology in Alzheimer's Disease.
1/2014	Matrix metalloproteinases and their multiple roles in Alzheimer's disease.
1/2014	Heat shock protein 90 in Alzheimer's disease.
1/2014	Prion-like Mechanisms in Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Tai Yu Research Topics

Disease

210	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 02/2009
57	Cognitive Dysfunction 03/2024 - 01/2014
56	Dementia (Dementias) 04/2024 - 01/2014
30	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 12/2012
21	Atrophy 03/2024 - 04/2012
16	Disease Progression 03/2024 - 04/2012
14	Stroke (Strokes) 04/2024 - 07/2014
14	Tauopathies 11/2023 - 10/2014
12	Inflammation (Inflammations) 04/2024 - 02/2011
11	Hypertension (High Blood Pressure) 01/2024 - 10/2013
11	Parkinson Disease (Parkinson's Disease) 03/2023 - 05/2014
9	Neuroinflammatory Diseases 12/2021 - 04/2012
9	Epilepsy (Aura) 05/2015 - 05/2010
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 02/2014
8	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 02/2014
8	Ischemic Stroke 12/2020 - 02/2010
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024 - 01/2014
6	Pathologic Constriction (Stenosis) 04/2020 - 01/2019
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 05/2013
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 11/2009
5	Infarction (Infarctions) 12/2020 - 07/2014
5	Seizures (Absence Seizure) 01/2015 - 05/2011
4	Nervous System Diseases (Neurological Disorders) 01/2023 - 10/2014
4	Obesity 01/2023 - 11/2020
4	Amyloid Plaque 11/2017 - 01/2014
4	Neoplasms (Cancer) 05/2015 - 10/2013
3	Anemia 01/2024 - 10/2022
3	Diabetes Mellitus 01/2023 - 01/2019
3	Hearing Loss (Hearing Impairment) 12/2022 - 01/2019
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022 - 10/2013
3	Pathologic Processes 01/2022 - 01/2016
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018 - 01/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2015 - 07/2014
2	Coronary Disease (Coronary Heart Disease) 04/2024 - 11/2021
2	Venous Thromboembolism 04/2024 - 01/2021
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2024 - 12/2022
2	Multiple System Atrophy 03/2023 - 01/2023
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2023 - 01/2023
2	Multiple Sclerosis 01/2023 - 01/2023
2	Hemorrhage 01/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

99	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
61	Amyloid (Amyloid Fibrils)IBA 03/2024 - 02/2011
29	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2013
17	Apolipoproteins E (ApoE)IBA 11/2023 - 04/2012
16	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 07/2012
14	tau Proteins (tau Protein)IBA 12/2022 - 05/2013
13	ApolipoproteinsIBA 01/2021 - 08/2013
12	Amyloid beta-PeptidesIBA 10/2023 - 11/2009
11	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2013
9	Peptides (Polypeptides)IBA 01/2019 - 02/2013
7	ClusterinIBA 01/2016 - 10/2010
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2022 - 05/2011
6	CytokinesIBA 01/2016 - 02/2009
5	Cystatin CIBA 04/2024 - 01/2022
5	LipidsIBA 01/2024 - 01/2020
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2023 - 11/2019
5	CholesterolIBA 04/2023 - 01/2015
5	Uric Acid (Urate)IBA 01/2022 - 04/2020
4	AlbuminsIBA 01/2024 - 01/2022
4	oxidized low density lipoproteinIBA 12/2023 - 01/2022
4	Carrier Proteins (Binding Protein)IBA 10/2022 - 02/2011
4	SynucleinsIBA 05/2022 - 11/2014
4	InflammasomesIBA 01/2015 - 12/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 01/2015
3	Alanine Transaminase (SGPT)IBA 12/2023 - 01/2022
3	Glial Fibrillary Acidic ProteinIBA 03/2023 - 01/2023
3	Vitamin D FDA LinkGeneric 01/2023 - 11/2016
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 11/2016
3	ProteomeIBA 01/2023 - 10/2021
3	Sex Hormone-Binding GlobulinIBA 10/2022 - 01/2020
3	NeurograninIBA 01/2022 - 01/2020
3	C-Reactive ProteinIBA 01/2022 - 01/2019
3	Complement System Proteins (Complement)IBA 01/2022 - 08/2010
3	CalciumIBA 06/2021 - 11/2009
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2020
3	ProgranulinsIBA 10/2020 - 01/2016
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2015
3	Memantine (Namenda)FDA Link 12/2018 - 01/2014
3	Phospholipases (Phospholipase)IBA 01/2016 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2016 - 10/2014
3	Vesicular Transport Adaptor ProteinsIBA 01/2016 - 04/2014
3	Toll-Like Receptor 2IBA 10/2011 - 02/2011
2	ORALIT (ORS)IBA 04/2024 - 01/2023
2	Blood Proteins (Serum Proteins)IBA 04/2024 - 02/2024
2	Insulin-Like PeptidesIBA 01/2024 - 11/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2024 - 10/2023
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2023
2	Air Pollutants (Pollutants, Air)IBA 01/2024 - 01/2023
2	Lipoproteins (Lipoprotein)IBA 01/2024 - 01/2022
2	Linoleic Acid (Linoleate)IBA 01/2024 - 01/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 10/2023
2	Citric Acid (Citrate)FDA LinkGeneric 12/2023 - 01/2022
2	Valine (L-Valine)FDA Link 12/2023 - 01/2023
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2022
2	HDL LipoproteinsIBA 12/2023 - 04/2023
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2023 - 01/2015
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 01/2023
2	CopperIBA 01/2023 - 01/2015

Therapy/Procedure

28	Therapeutics 01/2024 - 02/2011